HQL
abrdn Life Sciences Investors
HQL
HQL
54 hedge funds and large institutions have $73.9M invested in abrdn Life Sciences Investors in 2014 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
8.83% more ownership
Funds ownership: 14.47% → 23.3% (+8.8%)
Holders
54
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$7.6M | |
| 2 | +$6.25M | |
| 3 | +$4.71M | |
| 4 |
NIM
Needham Investment Management
New York
|
+$3.31M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$2.62M |
Top Sellers
| 1 | -$3.34M | |
| 2 | -$1.12M | |
| 3 | -$770K | |
| 4 |
BA
Bard Associates
Chicago,
Illinois
|
-$303K |
| 5 |
TJHA
Thomas J. Herzfeld Advisors
Miami Beach,
Florida
|
-$99.1K |